Publication:
Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol

Simple item page
dc.contributor.authorMartínez, Felipe
dc.contributor.authorTaramasco, Carla
dc.contributor.authorEspinoza, Manuel
dc.contributor.authorAcevedo, Johanna
dc.contributor.authorGoic, Carolina
dc.contributor.authorNervi, Bruno
dc.date.accessioned2025-01-14T16:50:48Z
dc.date.available2025-01-14T16:50:48Z
dc.date.issued2024
dc.description.abstractCancer, a pervasive global health challenge, necessitates chemotherapy or radiotherapy treatments for many prevalent forms. However, traditional follow-up approaches encounter limitations, exacerbated by the recent COVID-19 pandemic. Consequently, telemonitoring has emerged as a promising solution, although its clinical implementation lacks comprehensive evidence. This report depicts the methodology of a randomized trial which aims to investigate whether leveraging a smartphone app called Contigo for disease monitoring enhances self-reported quality of life among patients with various solid cancers compared to standard care. Secondary objectives encompass evaluating the app's impact on depressive symptoms and assessing adherence to in-person appointments. Randomization will be performed independently using an allocation sequence that will be kept concealed from clinical investigators. Contigo offers two primary functions: monitoring cancer patients' progress and providing educational content to assist patients in managing common clinical situations related to their disease. The study will assess outcomes such as quality of life changes and depressive symptom development using validated scales, and adherence to in-person appointments. Specific scales include the EuroQol Group's EQ-5D questionnaire and the Patient Health Questionnaire (PHQ-9). We hypothesize that the use of Contigo will assist and empower patients receiving cancer treatment, which will translate to better quality of life scores and a reduced incidence of depressive symptoms. All analyses will be undertaken with the intention-to-treat principle by a statistician unaware of treatment allocation. This trial is registered in ClinicalTrials under the registration number NCT06086990.
dc.description.versionVersión Publicada
dc.identifier.citationMartínez F, Taramasco C, Espinoza M, Acevedo J, Goic C, Nervi B. Effects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol. Methods Protoc. 2024 Mar 15;7(2):24. doi: 10.3390/mps7020024
dc.identifier.doihttps://doi.org/0.3390/mps7020024
dc.identifier.urihttps://hdl.handle.net/11447/9645
dc.language.isoen
dc.subjectAdverse events
dc.subjectCancer
dc.subjectInternet
dc.subjectOncology
dc.subjectPatient surveillance
dc.subjectQuality of life
dc.subjectSmartphone
dc.subjectTelemonitoring
dc.subjectToxicity
dc.titleEffects on Quality of Life of a Telemonitoring Platform amongst Patients with Cancer (EQUALITE): A Randomized Trial Protocol
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceMethods and protocols
dspace.entity.typePublication
relation.isAuthorOfPublication525e6967-5802-4c1a-b67f-35abb11bf1f1
relation.isAuthorOfPublication.latestForDiscovery525e6967-5802-4c1a-b67f-35abb11bf1f1

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Effects on Quality of Life of a Telemonitoring Platform amongstPatients with Cancer (EQUALITE) A Randomized Trial Protocol.pdf
Size:
942.02 KB
Format:
Adobe Portable Document Format
Description:
Texto Complerto
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services